Psoriasis associated with an increased risk of COVID-19 in real-world study
April 28, 2021
Those treated with TNF-alpha inhibitors, methotrexate, and apremilast had statistically lower risks of COVID-19 vs. those on topical therapy.
Rheumatologic disease activity an important influencer of COVID-19 death risk
February 5, 2021
COVID-19 Global Rheumatology Alliance physician registry data highlight need to maintain adequate disease control to lower risk for death from COVID-19.
COVID-19 vaccines: Safe for immunocompromised patients?
December 17, 2020
Data are limited thus far, and the safety and efficacy of the COVID-19 vaccines in immunocompromised patients remain unknown.
COVID-19 risks in rheumatic disease remain unclear
November 7, 2020
Elevated COVID-19-related risks, many associated with comorbidities, emerged in a match-control study, whereas a systematic review delivers more encouraging news for people living with rheumatic disease.
Biologics may protect psoriasis patients against severe COVID-19
November 2, 2020
Preliminary evidence suggests biologics prevent the fearsome COVID-19 late cytokine storm.
COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexate
September 16, 2020
No increase was seen in hospitalization and death rates, providing additional support for keeping patients on these immunosuppressive treatments during the COVID-19 pandemic, although more research is needed and shared decision making is warranted.
Even a few days of steroids may be risky, new study suggests
July 9, 2020
A retrospective study of more than 2.6 million Taiwanese adults echoes findings from a 2017 cohort study of more than 1.5 million U.S. adults.
ACIP approves flu vaccine recommendations for 2020-2021
June 25, 2020
Next season’s vaccination options include new high-dose quadrivalent vaccines for seniors.
Entheseal lesions, bone density linked with incident PsA in psoriasis patients
June 11, 2020
Metacarpal entheseal lesions and low entheseal bone density in patients with psoriasis each linked with increased incident psoriatic arthritis.
EULAR’s COVID-19 recommendations offer no surprises
June 11, 2020
The provisional recommendations cover four themes: general measures and preventing SARS-CoV-2 infection, managing patients without COVID-19 and those with the infection, and preventing COVID-19 lookalikes.